Jul 6, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Advances in 3D Printing of Biopharmaceuticals Modern technology has enabled the development of novel dosage forms for targeted therapy. However, the fabrication of novel dosage forms at industrial scale is limited and the industry still runs on conventional drug...
Jun 19, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Improving patient adherence of oral drug products remains a key challenge for drug manufacturers alike. Check out this article and discussion between Pharmaceutical Technology and Adare Pharmaceuticals which discusses a unique approach for industry. 2024 Controlled...
Jun 16, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Improving the solubility of poorly soluble APIs remains one of the biggest challenges for pharmaceutical companies. Not to mention the lengthy and costly drug approval processes, generic incursion, rising development costs and the need for novel adherence strategies,...
Jun 15, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Enhancing Drug Bioavailability and Solubility Approximately 40% of drugs on the market place and a high percentage of APIs in development are poorly soluble. Optimization of drug solubility and BA of therapeutics stands as one of the top challenges faced by the...
Jun 8, 2020 | Controlled Release, Drug Bioavailability, Main Blog, Peptide |
Extended Duration Parenteral Products as Patient Adherence Strategies For a number of years, extended-release parenteral formulations have garnered enormous attention due to their effective drug concentrations over extended periods and improve patient compliance...
Recent Comments